Cardinal Health, Inc. (NYSE:CAH) Receives $209.00 Average PT from Brokerages

Shares of Cardinal Health, Inc. (NYSE:CAH) have been given a consensus recommendation of “Moderate Buy” by the sixteen research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $212.60.

A number of analysts have issued reports on the stock. TD Cowen boosted their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Evercore ISI lifted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Jefferies Financial Group set a $220.00 price target on Cardinal Health and gave the stock a “buy” rating in a research report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft raised their price objective on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Finally, Robert W. Baird set a $232.00 target price on Cardinal Health in a research report on Friday, October 31st.

Cardinal Health Stock Down 0.7%

Shares of NYSE:CAH opened at $201.06 on Wednesday. Cardinal Health has a 12-month low of $119.25 and a 12-month high of $214.93. The business has a 50 day moving average of $204.05 and a 200-day moving average of $173.10. The stock has a market cap of $47.77 billion, a PE ratio of 30.33, a P/E/G ratio of 1.47 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period last year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts expect that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds and other institutional investors have recently made changes to their positions in CAH. Counterpoint Mutual Funds LLC bought a new position in shares of Cardinal Health during the 2nd quarter worth $1,911,000. Strs Ohio purchased a new stake in Cardinal Health during the first quarter valued at about $2,652,000. Baird Financial Group Inc. boosted its position in Cardinal Health by 107.2% during the second quarter. Baird Financial Group Inc. now owns 99,393 shares of the company’s stock worth $16,698,000 after purchasing an additional 51,416 shares during the period. Nomura Holdings Inc. boosted its position in Cardinal Health by 568.0% during the second quarter. Nomura Holdings Inc. now owns 85,293 shares of the company’s stock worth $14,329,000 after purchasing an additional 72,525 shares during the period. Finally, Voya Investment Management LLC increased its stake in shares of Cardinal Health by 298.3% in the third quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock worth $128,978,000 after purchasing an additional 615,398 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.